Literature DB >> 10074940

The molecular basis for protein kinase A anchoring revealed by solution NMR.

M G Newlon1, M Roy, D Morikis, Z E Hausken, V Coghlan, J D Scott, P A Jennings.   

Abstract

Compartmentalization of signal transduction enzymes into signaling complexes is an important mechanism to ensure the specificity of intracellular events. Formation of these complexes is mediated by specialized protein motifs that participate in protein-protein interactions. The adenosine 3',5'-cyclic monophosphate (cAMP)-dependent protein kinase (PKA) is localized through interaction of the regulatory (R) subunit dimer with A-kinase-anchoring proteins (AKAPs). We now report the solution structure of the type II PKA R-subunit fragment RIIalpha(1-44), which encompasses both the AKAP-binding and dimerization interfaces. This structure incorporates an X-type four-helix bundle dimerization motif with an extended hydrophobic face that is necessary for high-affinity AKAP binding. NMR data on the complex between RIIalpha(1-44) and an AKAP fragment reveals extensive contacts between the two proteins. Interestingly, this same dimerization motif is present in other signaling molecules, the S100 family. Therefore, the X-type four-helix bundle may represent a conserved fold for protein-protein interactions in signal transduction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074940     DOI: 10.1038/6663

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  58 in total

1.  A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes.

Authors:  M G Newlon; M Roy; D Morikis; D W Carr; R Westphal; J D Scott; P A Jennings
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 2.  Organization of kinases, phosphatases, and receptor signaling complexes.

Authors:  R V Schillace; J D Scott
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

3.  Characterization of Sp17: a ubiquitous three domain protein that binds heparin.

Authors:  Y Wen; R T Richardson; E E Widgren; M G O'Rand
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

4.  Bioinformatic design of A-kinase anchoring protein-in silico: a potent and selective peptide antagonist of type II protein kinase A anchoring.

Authors:  Neal M Alto; Scott H Soderling; Naoto Hoshi; Lorene K Langeberg; Rosa Fayos; Patricia A Jennings; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

5.  Designing isoform-specific peptide disruptors of protein kinase A localization.

Authors:  Lora L Burns-Hamuro; Yuliang Ma; Stefan Kammerer; Ulrich Reineke; Chris Self; Charles Cook; Gary L Olson; Charles R Cantor; Andreas Braun; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

Review 6.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Get5 carboxyl-terminal domain is a novel dimerization motif that tethers an extended Get4/Get5 complex.

Authors:  Justin W Chartron; David G VanderVelde; Meera Rao; William M Clemons
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

Review 8.  Networking with AKAPs: context-dependent regulation of anchored enzymes.

Authors:  Emily J Welch; Brian W Jones; John D Scott
Journal:  Mol Interv       Date:  2010-04

9.  Mechanism for targeting the A-kinase anchoring protein AKAP18δ to the membrane.

Authors:  Andreas Horner; Frank Goetz; Robert Tampé; Enno Klussmann; Peter Pohl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

10.  PKA-type I selective constrained peptide disruptors of AKAP complexes.

Authors:  Yuxiao Wang; Tienhuei G Ho; Eugen Franz; Jennifer S Hermann; F Donelson Smith; Heidi Hehnly; Jessica L Esseltine; Laura E Hanold; Mandi M Murph; Daniela Bertinetti; John D Scott; Friedrich W Herberg; Eileen J Kennedy
Journal:  ACS Chem Biol       Date:  2015-03-25       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.